Comparison · NCT01699503-sae
Screening Group vs No Screening: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Screening Group vs No Screening: serious adverse events. Trial comparisons, record NCT01699503-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01699503-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0302 | 0.0231 | 0.0394 | wilson | |
| Risk in group 2 | 0.0278 | 0.0209 | 0.0367 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00242 | -0.00901 | 0.0139 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.09 | 0.737 | 1.6 | log | |
| Odds ratio, group 1 over group 2 | 1.09 | 0.73 | 1.63 | log | |
| Number needed to harm, for one more participant with a serious adverse event on Screening Group than on No Screening | 413 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Screening Group | Subjects who are randomized into the screening arm of the study will be screened by the MIS. Subjects with MIS score of less than 5 points will be referred to the Collaborative Dementia Care Program for a subsequent diagnostic assessment, counseling and management.~Collaborative Dementia Care Program: Much of the intervention, facilitated by care coordinator, is targeted to co-manage or support the practice behavior of primary care clinicians, enhance self-management skills of both the care-recipient and the informal caregiver, and maximize the coping behavior of the patient and the informal caregiver. | 52 | 1,723 | EG000 |
| Group 2 | No Screening | Subjects who are randomized into the non-screening arm will receive the usual standard of care. | 47 | 1,693 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- 1 year
Source ClinicalTrials.gov
Trial
- Title
- Indiana University Dementia Screening Trial
- NCT number
- NCT01699503
- Phases
- NA
- Conditions
- Dementia, Alzheimer's Disease, Mild Cognitive Impairment
- Interventions
- Collaborative Dementia Care Program
- Lead sponsor
- Indiana University
- Results first posted
- 2019-01-23
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01699503?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01699503-sae